BMNDF (Biomind Labs) Short-Term Debt: $0.79 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Biomind Labs Short-Term Debt?

Biomind Labs BMNDF Short-Term Debt is $0.79 Mil as of Mar. 2026. The stock has 3 warning signs investors should review.

Biomind Labs's Short-Term Debt for the quarter that ended in Mar. 2026 was $0.79 Mil.

Biomind Labs's quarterly Short-Term Debt increased from Sep. 2025 ($0.69 Mil) to Dec. 2025 ($0.73 Mil) and increased from Dec. 2025 ($0.73 Mil) to Mar. 2026 ($0.79 Mil).

Biomind Labs's annual Short-Term Debt declined from Dec. 2023 ($0.74 Mil) to Dec. 2024 ($0.67 Mil) but then increased from Dec. 2024 ($0.67 Mil) to Dec. 2025 ($0.73 Mil).

Biomind Labs Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Biomind Labs Short-Term Debt Related Terms

Biomind Labs Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Biomind Labs's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biomind Labs Short-Term Debt Chart

Biomind Labs Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Short-Term Debt
0.00 0.00 0.74 0.67 0.73

Biomind Labs Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.63 0.65 0.69 0.73 0.79
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of $0.79 Mil mean?
Biomind Labs (BMNDF) has a Short-Term Debt of $0.79 Mil as of Mar. 2026.
Is Biomind Labs' Short-Term Debt too high?
Biomind Labs' current Short-Term Debt is $0.79 Mil.
How does Biomind Labs' Short-Term Debt compare to VRTX and REGN?
Biomind Labs' Short-Term Debt of $0.79 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Biotechnology company?
A good Short-Term Debt depends on the Biotechnology industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Biomind Labs's current Short-Term Debt is $0.79 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biomind Labs stock overvalued right now?
Biomind Labs (BMNDF) has a current Short-Term Debt of $0.79 Mil. The current Short-Term Debt is $0.79 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Biomind Labs (BMNDF), the current Short-Term Debt is $0.79 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biomind Labs Business Description

Other Exchanges BMND:Canada
Address 701 West Georgia Street, Suite 515, Vancouver, BC, CAN, V7Y 1C6
Biomind Labs Inc is a biotech research and development company aimed at transforming biomedical sciences knowledge from natural psychotropic plants into novel pharmaceutical drugs and nanotech delivery systems for a variety of psychiatric and neurological conditions. The firm is developing pharmaceutical solutions and combined formulations of the main natural psychedelic molecules with the objective of identifying novel pharmaceutical compounds for treating a wide range of therapeutic indications.